Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

China · Delayed Price · Currency is CNY

11.30

-0.15 (-1.31%)

Oct 23, 2026, 3:00 PM CST

Market Cap	4.52B -12.1%
Revenue (ttm)	1.56B -19.0%
Net Income	374.22K -99.8%
EPS	0.00 -99.8%
Shares Out	399.65M
PE Ratio	12,668.16
Forward PE	n/a
Dividend	0.06 (0.53%)
Ex-Dividend Date	Jun 30, 2026

Volume	15,303,900
Open	11.30
Previous Close	11.45
Day's Range	10.62 - 11.44
52-Week Range	9.51 - 17.46
Beta	0.97
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHA:603439

Guizhou Sanli Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the plantation, research, development, production, and sale of pharmaceutical products in China. The company offers respiratory system, tonifying, gynecological, and orthopedic medications, as well as cardiovascular and cerebrovascular drugs, and other medicines. It also provides products in various dosage forms, including sprays, granules, capsules, pills, tablets, medicated wines, and ointments. In addition, the company trades medicinal herbs. Guizhou Sanli Pharm... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1995

Employees 1,887

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603439

Full Company Profile

Financial Performance

In 2025, SHA:603439's revenue was 1.70 billion, a decrease of -20.59% compared to the previous year's 2.14 billion. Earnings were 46.25 million, a decrease of -83.12%.

Financial Statements